The difference between assuming and knowing
If we had the opportunity to gain a better understanding of the specific challenges our patients face and to minimize the uncertainty regarding how to help them, we would choose that, right? A new publication reinforces that this opportunity for clarity is already available.
Choosing a better patient pathway: Lessons from TCT 2020 and the FORECAST trial
In this issue, Dr. Campbell Rogers reviews the FORECAST trial, a randomized, controlled trial presented at TCT 2020 that assesses the real-world impact of a CT+HeartFlow pathway.
Are commercial insurance providers nudging us toward clinical improvements?
This article explores how commercial insurance providers impact the US healthcare system structure and reviews the recent “nudges” toward using coronary CTA to evaluate stable chest pain.
JACC Publication: “Current Evidence and Recommendations for Coronary CTA First in Evaluation of Stable CAD”
In this issue, Dr. Campbell Rogers shares his perspective on the ACC statement recommendations that indicates with strong rationale that the US should adopt a coronary CTA-first strategy for diagnosing CAD and that FFRCT should be a core component of this pathway.
Are UK Hospitals Better Prepared for COVID?
In 2016, the UK’s National Institute for Health and Care Excellence (NICE) released clinical guidance prioritizing a CCTA-first pathway for stable chest pain patients. This article explores the role of the guidance in better preparing UK hospitals for COVID-19.
How CCTA Can Inform LDL Treatment
There has been much debate on when to prescribe statins for LDL management. This issue focuses on a new publication that indicates how CCTA can inform clinicians about LDL treatment decisions.
Why Don’t We Take Good Advice?
Although cardiologists may know the importance of understanding coronary physiologic information in making treatment decisions, why don’t they use it more often? This article explores the disconnect.
Life May be on Pause. Your Health Isn’t.
Hospitals worldwide have seen a reduction in acute cardiac patients due to the COVID-19 pandemic. This article reviews the effects and guidance for hospitals issued by societies.
AHA Statement Supporting CCTA for CAD Diagnosis in Diabetic Patients
Patients with type 2 diabetes mellitus (T2DM) are likely to experience more aggressive cardiovascular disease development and progression than are patients with other comorbidities. This article reviews the role of CCTA in diagnosing CAD in patients with T2DM.
Why Coronary Anatomy & Physiology Are Not the Same
A review of the disconnect between coronary anatomy and physiology with a summary of data presented by Professor Nick Curzen and Dr. Jonathon Leipsic.
